INS and metabolic dysfunction-associated steatotic liver disease: Of the 45 obese volunteers, 27 (60%) would be defined as insulin resistant (homeostatic model assessment of insulin resistance>2.017), and 18 (40%) fulfilled the criteria for a diagnosis of nonalcoholic fatty liver disease (>5% liver fat).